ESR1 and breast cancer: The estrogen-mediated increase in GRP78, in breast cancer cells expressing estrogen receptor α [NR3A1] confers improved resistance to ER stress and cell proliferation both of which can be decreased through siRNA mediated knockdown of estrogen receptor α [64].